Skip to content

The economic and clinical impact of a clinical pharmacy team on surgical patients: the SUREPILL study.

The economic and clinical impact of a clinical pharmacy team on surgical patients: a randomised cost-effectiveness study.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25425
Enrollment
1444
Registered
2010-03-24
Start date
2008-10-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse Drug Events

Interventions

Three hospitals will participate. First, baseline assessments (n=480) will be made in each hospital at the surgical wards. Then, in each centre, one unit will randomly be assigned (one-time randomisat
2. Daily review of prescribed medication by hospital pharmacists
3. Medication reconciliation and couselling at discharge by pharmacy technicians.

Sponsors

- Academic Medical Centre Amsterdam Participating hospitals: - Onze lieve Vrouwe Gasthuis Amsterdam - Diakonessenhuis Utrecht
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Study ward: surgical ward; 2. Elective admitted for surgical procedure; 3. Hospital stay: > 48 hours.

Exclusion criteria

Exclusion criteria: 1. Patient already included in the study; 2. Admitted from other department within hospital or other hospital.

Design outcomes

Primary

MeasureTime frame
Number of preventable ADE's per 100 admissions.

Secondary

MeasureTime frame
1. Severity of all preventable ADE's; 2. Number and clinical relevance of pharmacy interventions; 3. Lenght of hospital stay; 4. Number of readmissions within 3 months after admission; 5. Costs; 6. Quality of life within 3 months after admission; 7. Additional quality of pharmaceutical care.

Contacts

Public ContactM. Boer, de

Meibergdreeg 9

m.deboer@amc.nl+31 (0)20 5663571

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)